Minnie Baylor-Henry
CIK 1747260 · last filed 2026-06-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.44M
Companies
5
Total Filings
37
Lifetime Open-Market Net
-$517
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| APYX | Director | — | $3.86 | — | $0 | 8 | 2026-06-15 |
| LNTH | Director | 14,034 | $102.64 | $1.44M | -$517 | 8 | 2026-05-18 |
| scPharmaceuticals Inc. (SCPH) Delisted | Director | — | $5.67 | — | $0 | 9 | 2025-10-07 |
| Paratek Pharmaceuticals, Inc. (PRTK) Delisted | Director | 26,400 | $2.23 | $58.9K | $0 | 4 | 2023-09-21 |
| POLARITYTE, INC. (PTE) Delisted | Director | 8,314 | $0.24 | $2.0K | $0 | 8 | 2021-01-05 |
Recent Filings · Page 2 of 4
37 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-10-13 | LNTH | Mixed | +16 | $1.1K | EDGAR |
| 2023-09-21 | Paratek Pharmaceuticals, Inc. (PRTK) Delisted | Disp (D) | −59,200 | $0 | EDGAR |
| 2023-08-15 | APYX | Grant (A) | — | $0 | EDGAR |
| 2023-06-08 | scPharmaceuticals Inc. (SCPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-15 | LNTH | Grant (A) | +2,012 | $0 | EDGAR |
| 2023-02-09 | Paratek Pharmaceuticals, Inc. (PRTK) Delisted | Grant (A) | +20,000 | $0 | EDGAR |
| 2022-08-17 | APYX | Grant (A) | — | $0 | EDGAR |
| 2022-06-15 | scPharmaceuticals Inc. (SCPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-12 | LNTH | Grant (A) | — | $0 | EDGAR |
| 2022-05-10 | LNTH | Grant (A) | +2,180 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.